Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice
Launched by METHODIST HEALTH SYSTEM · Feb 3, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how satisfied patients are with their care at various Methodist hospitals and clinics that specialize in neurosurgery. Researchers will review surveys filled out by patients between January 1, 2016, and December 31, 2020, to see how experiences in the hospital compare to those in outpatient (ambulatory) settings. The goal is to understand any connections between patient satisfaction scores from both settings.
To participate in this study, individuals need to be at least 18 years old and have completed a patient satisfaction survey related to their experience with a neurosurgeon at one of the Methodist hospitals or clinics during the specified time frame. If you choose to take part, you won’t need to do anything extra besides allowing researchers to use your survey responses. This study is currently recruiting participants, and it aims to improve the quality of care for future patients by learning from past experiences.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Completed a PG HCAHPS hospital and/or ambulatory survey between January 1, 2016 and December 31, 2020 in relation to a MHS neurosurgeon hospital and/or ambulatory visit
- Exclusion Criteria:
- • • Patients not meeting the study inclusion criteria in section 4.1
About Methodist Health System
Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Richard Meyrat, MD
Principal Investigator
Methodist
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials